Background To eliminate mother-to-child transmission (MTCT) of hepatitis B virus (HBV),
peripartum antiviral prophylaxis might be required for pregnant women infected with HBV …

Viral hepatitis is a major public health threat and a leading cause of death worldwide.
Annual mortality from viral hepatitis is similar to that of other major infectious diseases such …

WHO estimates that in 2015, 257 million people were living with chronic hepatitis B virus
(HBV) infection worldwide, and that 900 000 had died from HBV infection, mostly as a result …

These are the first World Health Organization (WHO) guidelines for the prevention care and
treatment of persons living with CHB infection and complement similar recent published …

Abstract In 2016 the World Health Organization set the goal of eliminating hepatitis B
globally by 2030. Horizontal transmission has been greatly reduced in most countries by …

In 2016, WHO member states at the World Health Assembly adopted a Global Health Sector
Strategy that included a policy of eliminating viral hepatitis. Clear targets were established to …

Background The risk of mother‐to‐child transmission of hepatitis B virus (HBV) has been
quoted as 70–90% among women positive for hepatitis B surface antigen (HB sAg) and e …

Summary Background In sub-Saharan Africa, administration of hepatitis B virus (HBV) birth-
dose vaccines remains suboptimal. Evidence is scarce on whether African countries should …

Background The natural history of chronic HBV infection in sub-Saharan Africa is unknown.
Data are required to inform WHO guidelines that are currently based on studies in Europe …

Objective Although vaccine coverage in infants in sub-Saharan Africa is high, this is
estimated at the age of 6–12 months. There is little information on the timely administration …